Bisphosphonates are a class of drugs that prevent the loss of bone mass, used to treat osteoporosis and similar diseases. They are the most commonly prescribed drugs used to treat osteoporosis. They are called bisphosphonates because they have two phosphonate (PO3) groups and are similar in structure to pyrophosphate.
The bisphosphonates are powerful, they cause dramatic changes in the bone physiology, and they deserve respect. In women or men whose bone density T-score is lower than -2.5, or who already have a vertebral fracture, these medicines reduce the incidence of fractures and improve the quality of life. Evidence shows that they reduce the risk of osteoporotic fracture in those who have had previous fractures.
Bisphosphonates are a class of drug used to treat and prevent osteoporosis.
Bisphosphonates drugs are primarily used for the treatment of osteoporosis. This drug has proven to be very effective in preventing fractures for people with this disease.
Bisphosphonates drugs are primarily used for the treatment of osteoporosis. This drug has proven to be very effective in preventing fractures for people with this disease.
It is pronounced "bi-sfos-fo-nayts".
The drug interactions that are additive when taking ipriflavone include bisphosphonates, calcitonin, estrogen, selective estrogen receptor modulators.
The treatment for osteoporosis is usually prescribed medications called bisphosphonates, such as alendronate and Ibandronate. Osteoporosis is a condition in which bones become brittle and very weak, leading to bone fractures.
Paul A DeLange has written: 'The effect of bisphosphonates on macrophage synthesis and secretion of acid phosphatase--a bone resorbing enzyme' -- subject(s): Physiological effect, Diphosphonates
Bisphosphonates are the primary class of drugs that inhibit the breakdown of bone. They work by binding to the bone mineral matrix and preventing osteoclasts from breaking down bone tissue. Other medications, such as denosumab (a monoclonal antibody) and selective estrogen receptor modulators (SERMs) like raloxifene, also have similar effects on bone breakdown. These drugs are commonly used in the treatment of osteoporosis and other bone-related conditions.
A bisphosphonate is any of a class of organic compounds with two phosphate groups attached to a single carbon atom, or any of a group of several pharmaceuticals with this structure, intended to treat Paget's disease.
Bisphosphonates, calcitonin, and denosumab are examples of medications that inhibit osteoclast activity by reducing bone resorption. Additionally, a high level of calcium in the blood can also inhibit osteoclast activity.
Osteonecrosis of the jaw, generally associated with tooth extraction and/or local infection, often with delayed healing, has been reported in patients taking bisphosphonates(fosamax).
* Intravenous fluids * Bisphosphonates (drugs that stop bone resorption such as pamidronate or etidronate) * Calcitonin * Glucocorticoids (steroids, for hypervitaminosis D that is not medication related) * Hemodialysis (for hypercalcemia that is unresponsive to treatment and is life-threatening)